Omega-3 polyunsatured fatty acids and health: A mini-review of current knowledge;Acides gras polyinsaturés en oméga-3 et santé: Apeŗu des connaissances actuelles

Sciences des Aliments

Volumn 26, Issue 1, 2006, Pages 8-28

  Astorg, P ^a,c   Guesnet, P ^b   Alessandri, J M ^b   Galan, P ^a   Lavialle, M ^b  

^a INSERM   (France)

^b CEMAGREF   (France)

^c Bioinformatique et Chimie Moléculaire   (France)

Author keywords

Alpha linolenic acid; DHA; EPA; Health; Omega 3 fatty acids

Indexed keywords

EID: 33644504226     PISSN: 02408813     EISSN: None     Source Type: Journal    
DOI: 10.3166/sda.26.8-28     Document Type: Short Survey

References (101)

1. AILHAUD G. and GUESNET P. (2004). Fatty acid composition of fats is an early determinant of childhood obesity: a short review and an opinion. Obes. Rev., 5, 21-26.
2. ALESSANDRI J.M., GUESNET P., VANCASSEL S., ASTORG P., DENIS I., LANGELIER B., AÏD S., POUMÈS-BALLIHAUT C., CHAMPEIL-POTOKAR G. and LAVIALLE M. (2004). Polyunsaturated fatty acids in the central nervous system: evolution of concepts and nutritional implications throughout life. Reprod. Nutr. Develop., 44.
3. ANDERSON M. and FRITSCHE K.L. (2002). (n-3) Fatty acids and infectious disease resistance. J Nutr, 132, 3566-3576.
4. ASTORG P. (2003). Acides gras polyinsaturés en n-3 et dépression: des espoirs pour la prévention et la thérapeutique. NAFAS, 1, 11-19.
5. ASTORG P. (2004). Dietary N-6 and N-3 polyunsaturated fatty acids and prostate cancer risk: a review of epidemiological and experimental evidence. Cancer Causes Control, 15, 367-386.
6. ASTORG P., ARNAULT N., CZERNICHOW S., NOISETTE N., GALAN P. and HERCBERG S. (2004). Dietary intakes and food sources of n-6 and n-3 PUFA in French adult men and women. Lipids, 39, 527-535.
7. AUESTAD N., MONTALTO M.B., HALL R.T., FITZGERALD K.M., WHEELER R.E., CONNOR W.E., NEURINGER M., CONNOR S.L., TAYLOR J.A. and HARTMANN E.E. (1997). Visual acuity, erythrocyte fatty acid composition, and growth in term infants fed formulas with long chain polyunsaturated fatty acids for one year. Ross Pediatric Lipid Study. Pediatr. Res., 41, 1-10.
8. BARBERGER-GATEAU P., LETENNEUR L., DESCHAMPS V., PERES K., DARTIGUES J.F. and RENAUD S. (2002). Fish, meat, and risk of dementia: cohort study. BMJ, 325, 932-933.
9. BELLUZZI A. (2002). N-3 fatty acids for the treatment of inflammatory bowel diseases. Proc. Nutr Soc., 61, 391-395.
10. BOUGNOUX P., MAILLARD V., FERRARI P., JOURDAN M.L. and CHAJES V. (2002). n-3 fatty acids and breast cancer. IARC Sci. Publ., 156, 337-341.
11. BRENNA J.T. (2002). Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man. Curr. Opin. Clin. Nutr. Metab Care, 5, 127-132.
12. BROWNING L.M. (2003). n-3 Polyunsaturated fatty acids, inflammation and obesity-related disease. Proc. Nutr Soc., 62, 447-453.
13. BURDGE G. (2004). Alpha-linolenic acid metabolism in men and women: nutritional and biological implications. Curr. Opin. Clin. Nutr. Metab Care, 7, 137-144.
14. BURR M.L., ASHFIELD-WATT P.A., DUNSTAN F.D., FEHILY A.M., BREAY P., ASHTON T., ZOTOS P.C., HABOUBI N.A. and ELWOOD P.C. (2003). Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur. J Clin. Nutr, 57, 193-200.
15. BURR M.L, FEHILY A.M., GILBERT J.F., ROGERS S., HOLLIDAY R.M., SWEETNAM P.M., ELWOOD P.C. and DEADMAN N.M. (1989). Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet, 2, 757-761.
16. CALDER P.C. (2002). Dietary modification of inflammation with lipids. Proc. Nutr Soc., 61, 345-358.
17. CALDER P.C. (2004). n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin. Sci. (Lond), 107, 1-11.
18. CHAJÈS V. and BOUGNOUX P. (2003). Omega-6/omega-3 polyunsaturated fatty acid ratio and cancer. World Rev. Nutr Diet., 92, 133-151.
19. CLELAND L.G., JAMES M.J. and PROUDMAN S.M. (2003). Omega-6/omega-3 fatty acids and arthritis. World Rev. Nutr Diet., 92, 152-168.
20. COLOMBO J., KANNASS K.N., SHADDY D.J., KUNDURTHI S., MAIKRANZ J.M., ANDERSON C.J., BLAGA O.M. and CARLSON S.E. (2004). Maternal DHA and the development of attention in infancy and toddlerhood. Child Dev., 75, 1254-1267.
21. COMBE N. and BOUÉ C. (2001). Apports alimentaires en acides linoléique et alpha-linolénique d'une population d'Aquitaine. Oléag. Corps Gras Lipides, 8, 118-121.
22. CUNNANE S.C., FRANCESCUTTI V., BRENNA J.T. and CRAWFORD M.A. (2000). Breastfed infants achieve a higher rate of brain and whole body docosahexaenoate accumulation than formula-fed infants not consuming dietary docosahexaenoate. Lipids, 35, 105-111.
23. DALLONGEVILLE J., YARNELL J., DUCIMETIERE P., ARVEILER D., FERRIERES J., MONTAYE M., LUC G., EVANS A., BINGHAM A., HASS B., RUIDAVETS J.B. and AMOUYEL P. (2003). Fish consumption is associated with lower heart rates. Circulation, 108, 820-825.
24. DE CATERINA R., MADONNA R., and MASSARO M. (2004). Effects of omega-3 fatty acids on cytokines and adhesion molecules. Curr. Atheroscler. Rep., 6, 485-491.
25. DE GROOT R.H., HORNSTRA G., VAN HOUWELINGEN A.C. and ROUMEN F. (2004). Effect of alpha-linolenic acid supplementation during pregnancy on maternal and neonatal polyunsaturated fatty acid status and pregnancy outcome. Am. J Clin. Nutr, 79, 251-260.
26. DE LORGERIL M. and SALEN P. (2004). Alpha-linolenic acid and coronary heart disease. Nutr Metab Cardiovasc. Dis., 14, 162-169.
27. DE LORGERIL M., SALEN P., MARTIN J.L., MONJAUD I., DELAYE J. and MAMELLE N. (1999). Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation, 99, 779-785.
28. DELARUE J., LEFOLL C., CORPOREAU C. and LUCAS D. (2004). N-3 long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity? Reprod. Nutr Dev., 44, 289-299.
29. DEMAISON L. and MOREAU D. (2002). Dietary n-3 polyunsaturated fatty acids and coronary heart disease-related mortality: a possible mechanism of action. Cell Mol. Life Sci., 59, 463-477.
30. DESCOMPS B. (2004). Les désaturases au cours du développement chez l'homme. Cah. Nutr. Diet, 38, 384-391.
31. EMSLEY R., OOSTHUIZEN P. and VAN RENSBURG S.J. (2003). Clinical potential of omega-3 fatty acids in the treatment of schizophrenia. CNS. Drugs, 17, 1081-1091.
32. ERITSLAND J. (2000). Safety considerations of polyunsaturated fatty acids. Am. J Clin. Nutr, 71, 197S-201S.
33. GALAN P., DE BREE A., MENNEN L, POTIER D.C., PREZIOZI P., BERTRAIS S., CASTETBON K. and HERCBERG S. (2003). Background and rationale of the SU.FOL.OM3 study: double-blind randomized placebo-controlled secondary prevention trial to test the impact of supplementation with folate, vitamin B6 and B12 and/or omega-3 fatty acids on the prevention of recurrent ischemic events in subjects with atherosclerosis in the coronary or cerebral arteries. J Nutr Health Aging, 7, 428-435.
34. GISSI-Prevenzione Investigators (1999). Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet, 354, 447-455.
35. Groupe de travail AFSSA. Acide gras de la famille oméga 3 et système cardiovasculaire: intérêt nutritionnel et allégations. 2003. Ref Type: Report.
36. Groupe de travail AFSSA-NACRe. Acides gras alimentaires et cancers: état des connaissances et perspectives. 2003. Ref Type: Report
37. GRYNBERG A. (2003). Coeur et nutrition: quels acides gras pour quelles fonctions cardiaques? Arch. Mal. Coeur Vaiss., 96, 7-12.
38. GUESNET P. and ALESSANDRI J.-M. (1995a). Acides gras polyinsaturés du lait et développement du système nerveux central du nouveau-né. Cah Nutr Diét, 30, 109-116.
39. GUESNET P., COUET C., ALESSANDRI J.-M., ANTOINE J.-M. and DURAND G. (1995b). Variabilité de la teneur en acide linoléique (18:2 n-6) et du rapport 18:2 n-6/18:3 n-3 des lipides dans le lait de femme en France. Annales de Pédiatrie (Paris), 42, 282-288.
40. GUESNET P., PUGO-GUNSAM P., MAURAGE C., PINAULT M., GIRAUDEAU B., ALESSANDRI J.M., DURAND G., ANTOINE J.M. and COUET C. (1999). Blood lipid concentrations of docosahexaenoic and arachidonic acids at birth determine their relative postnatal changes in term infants fed breast milk or formula. Am. J Clin. Nutr, 70, 292-298.
41. HAMAZAKI T., SAWAZAKI S., ITOMURA M., NAGAO Y., THIENPRASERT A., NAGASAWA T. and WATANABE S. (2001). Effect of docosahexaenoic acid on hostility. World Rev. Nutr Diet., 88, 47-52.
42. HARBIGE L.S. (2003). Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3. Lipids, 38, 323-341.
43. HE K., SONG Y., DAVIGLUS M.L, LIU K., VAN HORN L., DYER A.R., GOLDBOURT U. and GREENLAND P. (2004a). Fish consumption and incidence of stroke: a meta-analysis of cohort studies. Stroke, 35, 1538-1542.
44. HE K., SONG Y., DAVIGLUS M.L., LIU K., VAN HORN L., DYER A.R., and GREENLAND, P. (2004b). Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation, 109, 2705-2711.
45. HIBBELN J.R. (1998). Fish consumption and major depression. Lancet, 351, 1213.
46. HIBBELN J.R. (2001). Seafood consumption and homicide mortality. A cross-national ecological analysis. World Rev. Nutr Diet., 88, 41-46.
47. HIBBELN J.R. (2002). Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J Affect. Disord., 69, 15-29.
48. HOOPER L, THOMPSON R., HARRISON R., SUMMERBELL C., MOORE H., WORTHINGTON H., DURRINGTON P., NESS A., CAPPS N., DAVEY S.G., RIEMERSMA R. and EBRAHIM S. (2004). Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane. Database. Syst. Rev., CD003177.
49. HUAN M., HAMAZAKI K., SUN Y., ITOMURA M., LIU H., KANG W., WATANABE S., TERASAWA K. and HAMAZAKI T. (2004). Suicide attempt and n-3 fatty acid levels in red blood cells: a case control study in China. Biol. Psychiatry, 56, 490-496.
50. HULSHOF K.F.A.M., VAN ERP-BAART M.A., ANTTOLAINEN M., BECKER W., CHURCH S.M., COUET C., HERRMANNKUNZ E., KESTELOOT H., LETH T., and MARTINS I. (1999). Intake of fatty acids in Western europe with emphasis on trans fatty acids: the TRANSFAIR study. Eur. J. Clin. Nutr., 53, 143-157.
51. JENSEN C.L., PRAGER T.C., FRALEY J.K., CHEN H., ANDERSON R.E. and HEIRD W.C. (1997). Effect of dietary linoleic/alpha-linolenic acid ratio on growth and visual function of term infants. J Pediatr., 131, 200-209.
52. JOY C.B., MUMBY-CROFT R. and JOY L.A. (2003). Polyunsaturated fatty acid supplementation for schizophrenia. Cochrane. Database. Syst. Rev., CD001257.
53. KRIS-ETHERTON P.M., HARRIS W.S. and APPEL L.J. (2002). Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation, 106, 2747-2757.
54. KRIS-ETHERTON P.M., HARRIS W.S. and APPEL L.J. (2003). Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler. Thromb. Vasc. Biol., 23, 151-152.
55. LARSSON S.C., KUMLIN M., INGELMANSUNDBERG M. and WOLK A. (2004). Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am. J Clin. Nutr, 79, 935-945.
56. LAURITZEN L., HANSEN H.S., JORGENSEN M.H. and MICHAELSEN K.F. (2001). The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog. Lipid Res., 40, 1-94.
57. LAURITZEN L, JORGENSEN M.H., MIKKELSEN T.B., SKOVGAARD M., STRAARUP E.M., OLSEN S.F., HOY C.E. and MICHAELSEN K.F. (2004). Maternal fish oil supplementation in lactation: effect on visual acuity and n-3 fatty acid content of infant erythrocytes. Lipids, 39, 195-206.
58. LEAF A., KANG J.X., XIAO Y.F. and BILLMAN G.E. (2003). Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation, 107, 2646-2652.
59. LECERF J.-M. (2004). Poisson, acides gras oméga 3 et risque cardiovasculaire: données épidémiologiques. Cah. Nutr Diet, 39, 143-150.
60. LEGRAND P., BOURRE J.M., DESCOMPS B., DURAND G. and RENAUD S. (2001). Lipides. In: MARTIN A. (Ed.), Apports nutritionnels conseillés pour la population fraņaise. Technique & Documentation, Paris, pp. 63-82.
61. LEITZMANN M.F., STAMPFER M.J., MICHAUD D.S., AUGUSTSSON K., COLDITZ G.G., WILLETT W.C. and GIOVANNUCCI E.L. (2004). Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancer. Am. J Clin. Nutr, 80, 204-216.
62. LOCKE C.A. and STOLL A.L. (2001). Omega-3 fatty acids in major depression. World Rev. Nutr Diet, 89, 173-185.
63. LOGAN A.C. (2003). Neurobehavioral aspects of omega-3 fatty acids: possible mechanisms and therapeutic value in major depression. Altern. Med. Rev., 8, 410-425.
64. LOGAN A.C. (2004). Omega-3 fatty acids and major depression: A primer for the mental health professional. Lipids Health Dis., 3, 25.
65. MAHADIK S.P. and EVANS D.R. (2003). Is schizophrenia a metabolic brain disorder? Membrane phospholipid dysregulation and its therapeutic implications. Psychiatr. Clin. North Am., 26, 85-102.
66. MAKRIDES M., NEUMANN M., SIMMER K., PATER J. and GIBSON, R. (1995). Are long-chain polyunsaturated fatty acids essential nutrients in infancy? Lancet, 345, 1463-1468.
67. MAMALAKIS G., TORNARITIS M. and KAFATOS A. (2002). Depression and adipose essential polyunsaturated fatty acids. Prostaglandins Leukot Essent. Fatty Acids, 67, 311-318.
68. MATHAI M.L., SOUEID M., CHEN N., JAYASOORIYA A.P., SINCLAIR A.J., WLODEK M.E., WEISINGER H.S. and WEISINGER R.S. (2004). Does perinatal omega-3 polyunsaturated fatty acid deficiency increase appetite signaling? Obes. Res., 12, 1886-1894.
69. MORI T.A., WOODMAN R.J., BURKE V., PUDDEY I.B., CROFT K.D. and BEILIN L.J. (2003). Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects. Free Radic. Biol. Med, 35, 772-781.
70. MORRIS M.C., EVANS D.A., BIENIAS J.L., TANGNEY C.C., BENNETT D.A., WILSON R.S., AGGARWAL N. and SCHNEIDER J. (2003). Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch. Neurol., 60, 940-946.
71. NOAGHIUL S. and HIBBELN J.R. (2003). Cross-national comparisons of seafood consumption and rates of bipolar disorders. Am. J Psychiatry, 160, 2222-2227.
72. PEET M. (2003). Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results. Prostaglandins Leukot. Essent. Fatty Acids, 69, 477-485.
73. PEET M. and HORROBIN D.F. (2002a). A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms. J Psychiatr. Res., 36, 7-18.
74. PEET M. and HORROBIN D.F. (2002b). A dose-ranging study of the effects of ethyleicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch. Gen. Psychiatry, 59, 913-919.
75. PRESCOTT S.L. and CALDER P.C. (2004). N-3 polyunsaturated fatty acids and allergic disease. Curr. Opin. Clin. Nutr Metab Care, 7, 123-129.
76. REDDY B.S. (2004). Omega-3 fatty acids in colorectal cancer prevention. Int. J Cancer, 112, 1-7.
77. RIVELLESE A.A. and LILLI S. (2003). Quality of dietary fatty acids, insulin sensitivity and type 2 diabetes. Biomed. Pharmacother, 57, 84-87.
78. ROSE D.P. and CONNOLLY J.M. (1999). Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol. Ther., 83, 217-244.
79. ROYNETTE C.E., CALDER P.C., DUPERTUIS Y.M. and PICHARD C. (2004). n-3 polyunsaturated fatty acids and colon cancer prevention. Clin. Nutr, 23, 139-151.
80. SAWA S.C., CHADJIGEORGIOU C., HATZIS C., KYRIAKAKIS M., TSIMBINOS G., TORNARITIS M. and KAFATOS A. (2004). Association of adipose tissue arachidonic acid content with BMI and overweight status in children from Cyprus and Crete. Br. J Nutr, 91, 643-649.
81. SCHMIDT E.B., ARNESEN H., CHRISTENSEN J.H., RASMUSSEN L.H., KRISTENSEN S.D. and DE CATERINA R. (2005a). Marine n-3 polyunsaturated fatty acids and coronary heart disease Part II: Clinical trials and recommendations. Thromb. Res., 115, 257-262.
82. SCHMIDT E.B., ARNESEN H., DE CATERINA R., RASMUSSEN L.H. and KRISTENSEN S.D. (2005b). Marine n-3 polyunsaturated fatty acids and coronary heart disease Part I. Background, epidemiology, animal data, effects on risk factors and safety. Thromb. Res., 115, 163-170.
83. SIMOPOULOS A.P. (2002). Omega-3 fatty acids in inflammation and autoimmune diseases. J Am. Coll. Nutr, 21, 495-505.
84. SIMOPOULOS A.P., LEAF A. and SALEM N., Jr. (2000). Workshop statement on the essentiality of and recommended dietary intakes for Omega-6 and Omega-3 fatty acids. Prostaglandins Leukot. Essent. Fatty Acids, 63, 119-121.
85. SINCLAIR A.J., ATTAR-BASHI N.M. and LI D. (2002). What is the role of alpha-linolenic acid for mammals? Lipids, 37, 1113-1123.
86. SINGH R.B., NIAZ M.A., SHARMA J.P., KUMAR R., RASTOGI V. and MOSHIRI M. (1997). Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival-4. Cardiovasc. Drugs Ther., 11, 485-491.
87. SKERRETT P.J. and HENNEKENS C.H. (2003). Consumption of fish and fish oils and decreased risk of stroke. Prev. Cardiol., 6, 38-41.
88. SKOSNIK P.D. and YAO J.K. (2003). From membrane phospholipid defects to altered neurotransmission: is arachidonic acid a nexus in the pathophysiology of schizophrenia? Prostaglandins Leukot. Essent. Fatty Acids, 69, 367-384.
89. STOLL A.L., SEVERUS W.E., FREEMAN M.P., RUETER S., ZBOYAN H.A., DIAMOND E., CRESS K.K. and MARANGELL L.B. (1999). Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch. Gen. Psychiatry, 56, 407-412.
90. TANSKANEN A., HIBBELN J.R., TUOMILEHTO J., UUTELA A., HAUKKALA A., VIINAMAKI H., LEHTONEN J. and VARTIAINEN E. (2001). Fish consumption and depressive symptoms in the general population in Finland. Psychiatr. Serv., 52, 529-531.
91. TERRY P.D., TERRY J.B. and ROMAN T.E. (2004). Long-chain (n-3) fatty acid intake and risk of cancers of the breast and the prostate: recent epidemiological studies, biological mechanisms, and directions for future research. J Nutr, 134, 3412S-3420S.
92. TIMONEN M., HORROBIN D., JOKELAINEN J., LAITINEN J., HERVA A. and RASANEN P. (2004). Fish consumption and depression: the Northern Finland 1966 birth cohort study. J Affect Disord., 82, 447-452.
93. VANCASSEL S., DURAND G., BARTHELEMY C., LEJEUNE B., MARTINEAU J., GUILLOTEAU D., ANDRES C. and CHALON S. (2001). Plasma fatty acid levels in autistic children. Prostaglandins Leukot. Essent. Fatty Acids, 65, 1-7.
94. VANSCHOONBEEK K., DE MAAT M.P. and HEEMSKERK J.W. (2003). Fish oil consumption and reduction of arterial disease. J Nutr, 133, 657-660.
95. WHELTON S.P., HE J., WHELTON P.K. and MUNTNER P. (2004). Meta-analysis of observational studies on fish intake and coronary heart disease. Am. J Cardiol., 93, 1119-1123.
96. WIJENDRAN V. and HAYES K.C. (2004). Dietary n-6 and n-3 fatty acid balance and cardiovascular health. Annu. Rev. Nutr, 24, 597-615.
97. WONG K.W. (2005). Clinical efficacy of n-3 fatty acid supplementation in patients with asthma. J Am. Diet. Assoc., 105, 98-105.
98. YAVIN E., BRAND A., and GREEN P. (2002). Docosahexaenoic acid abundance in the brain: a biodevice to combat oxidative stress. Nutr Neurosci., 5, 149-157.
99. YOUNG G. and CONQUER J. (2005). Omega-3 fatty acids and neuropsychiatric disorders. Reprod. Nutr. Develop.
100. ZANARINI M.C. and FRANKENBURG F.R. (2003). omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. Am. J Psychiatry, 160, 167-169.
101. ZHANG J., SASAKI S., AMANO K. and KESTELOOT H. (1999). Fish consumption and mortality from all causes, ischemic heart disease, and stroke: an ecological study. Prev. Med., 28, 520-529.